Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Relaxin Family Peptide Receptor (RXFP1) Coupling to Gαi3 Involves the C-Terminal Arg752 and Localization within Membrane Raft Microdomains

Michelle L. Halls, Emma T. van der Westhuizen, John D. Wade, Bronwyn A. Evans, Ross A. D. Bathgate and Roger J. Summers
Molecular Pharmacology February 2009, 75 (2) 415-428; DOI: https://doi.org/10.1124/mol.108.051227
Michelle L. Halls
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emma T. van der Westhuizen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John D. Wade
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bronwyn A. Evans
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ross A. D. Bathgate
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roger J. Summers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The relaxin family peptide receptors (RXFP) 1 and 2 are targets for the relaxin family peptides relaxin and insulin-like peptide 3 (INSL3), respectively. Although both receptors and peptides share a high degree of sequence identity, the cAMP signaling pathways activated by the two systems are quite distinct. Relaxin activation of RXFP1 initially results in accumulation of cAMP via Gαs, but this is modulated by inhibition of cAMP through GαoB. Over time, RXFP1 recruits coupling to Gαi3, causing additional cAMP accumulation via a Gαi3-Gβγ-phosphoinositide 3-kinase (PI3K)-protein kinase C (PKC)ζ pathway. In contrast, INSL3 activation of RXFP2 results in accumulation of cAMP only via Gαs, modulated by cAMP inhibition through GαoB. Thus, the aim of this study was to identify the cause of differential G-protein coupling between these highly similar receptors. Construction of chimeric receptors revealed that Gαi3 coupling is dependent upon the transmembrane region of RXFP1 and independent of the receptor ectodomain or ligand bound. Generation of C-terminal truncated receptors identified the terminal 10 amino acids of the RXFP1 C terminus as essential for Gαi3 signaling, and point mutations revealed an obligatory role for Arg752. RXFP1-mediated Gαi3, but not Gαs or GαoB, signaling was also found to be dependent upon membrane rafts, and RXFP1 coupled to Gαi3 after only 3 min of receptor stimulation. Therefore, RXFP1 coupling to the Gαi3-Gβγ-PI3K-PKCζ pathway requires the terminal 10 amino acids of the RXFP1 C terminus and membrane raft localization, and the observed delay in this pathway occurs downstream of Gαi3.

Footnotes

  • This work was supported in part by the National Health and Medical Research Council [Block Grant Reg Key 983001, Project Grants 300012 and 436713] and ARC Linkage Grant LP0560620.

  • ABBREVIATIONS: INSL, insulin-like peptide; RXFP, relaxin family peptide receptor; PI3K, phosphoinositide 3-kinase; PKC, protein kinase C; PTX, pertussis toxin; LY294002, 2-(4-morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride; mGαi3,Gαi3 with Cys351-to-Ile mutation (PTX-insensitive); mGαoB,GαoB with Cys351-to-Ile mutation (PTX-insensitive); βARK-ct, β-adrenergic receptor kinase 1 C terminus; PCR, polymerase chain reaction; bp, base pair(s); GTPγS, guanosine 5′-O-(3-thio)triphosphate; ANOVA, analysis of variance; FBS, fetal bovine serum; HEK, human embryonic kidney; MES, 2-[N-morpholino]ethanesulfonic acid; MBS, MES-buffered saline; TBS-T, Tris-buffered saline with 0.1% Tween 20; TM, transmembrane helix.

    • Received August 8, 2008.
    • Accepted November 24, 2008.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 75 (2)
Molecular Pharmacology
Vol. 75, Issue 2
1 Feb 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Relaxin Family Peptide Receptor (RXFP1) Coupling to Gαi3 Involves the C-Terminal Arg752 and Localization within Membrane Raft Microdomains
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Relaxin Family Peptide Receptor (RXFP1) Coupling to Gαi3 Involves the C-Terminal Arg752 and Localization within Membrane Raft Microdomains

Michelle L. Halls, Emma T. van der Westhuizen, John D. Wade, Bronwyn A. Evans, Ross A. D. Bathgate and Roger J. Summers
Molecular Pharmacology February 1, 2009, 75 (2) 415-428; DOI: https://doi.org/10.1124/mol.108.051227

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Relaxin Family Peptide Receptor (RXFP1) Coupling to Gαi3 Involves the C-Terminal Arg752 and Localization within Membrane Raft Microdomains

Michelle L. Halls, Emma T. van der Westhuizen, John D. Wade, Bronwyn A. Evans, Ross A. D. Bathgate and Roger J. Summers
Molecular Pharmacology February 1, 2009, 75 (2) 415-428; DOI: https://doi.org/10.1124/mol.108.051227
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • EIPA, HMA and SMN2 gene regulation
  • Clc-2 has minor role in intestinal Cl- secretion
  • Resveratrol acts as an NR4A1 antagonist in lung cancer.
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics